特瑞氟米特
医学
多发性硬化
奥图穆马
单克隆抗体
CD20
药理学
皮肤病科
抗体
免疫学
芬戈莫德
作者
Stephen L. Hauser,Amit Bar‐Or,Jeffrey Cohen,Gıancarlo Comı,Jorge Correale,Patricia K. Coyle,Anne H. Cross,de Sèze,David Leppert,Xavier Montalbán,Krzysztof Selmaj,Heinz Wiendl,Cécile Kerloëguen,Roman Willi,Bingbing Li,Algirdas Kakarieka,Davorka Tomic,Alexandra Goodyear,Ratnakar Pingili,Dieter A. Häring
标识
DOI：10.1056/nejmoa1917246
摘要
Ofatumumab, a subcutaneous anti-CD20 monoclonal antibody, selectively depletes B cells. Teriflunomide, an oral inhibitor of pyrimidine synthesis, reduces T-cell and B-cell activation. The relative effects of these two drugs in patients with multiple sclerosis are not known.
科研通智能强力驱动
Strongly Powered by AbleSci AI
SYLH
cdercder
许甜甜鸭
hjyylab
等待冬亦
个性归尘
nozero
彭于彦祖
昏睡的蟠桃
冰魂
wangrblzu
科研助手6
sunyz
一一
iNk
coolkid
从容芮
22222
HEIKU
若雨凌风
皖公网安备34019202002308
